ChartRow logo
Share this page
VKTX
$25.17-8.04%
as of close, Oct 16, 2026
☾ AH $25.17 -8.04%
PeersMRNALLYMDTUNHJNJTMO

Viking Therapeutics Inc. trailing returns

Viking Therapeutics Inc.'s 10-year return is +36.8% a year (CAGR) (+2188.2% cumulative). How Viking Therapeutics Inc. (VKTX) has performed over the last day, week, month and year, over 5 and 10 years, and since inception, through October 16, 2026 — price return and dividends side by side, with the worst drop inside each window.

Trailing returns by period#

To 2026-10-16. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.

PeriodPriceDivsTotalWorst drop
1 day-8.0%+0.0%-8.0%—
5 days-11.7%+0.0%-11.7%-11.7%Oct 16
1 month-14.7%+0.0%-14.7%-39.6%Oct 16
YTD-28.5%+0.0%-28.5%-40.3%Oct 16
1 year-27.5%+0.0%-27.5%-40.3%Oct 2026
5 years+33.2%+0.0%+33.2%+318.8%-78.9%Apr 2025
10 years+36.8%+0.0%+36.8%+2188.2%-89.3%Jun 2022
Since inception (2015)+10.5%+0.0%+10.5%+214.6%-90.4%Aug 2017

Growth of VKTX#

Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.

  • 5 years+33.2%/year · +318.8%
  • 10 years+36.8%/year · +2188.2%

Methodology#

Trailing returns measure from the closest close about N years before the latest close (2026-10-16). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in VKTX's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.

FAQ#

What is Viking Therapeutics Inc.'s 10-year return?
Over the last 10 years, Viking Therapeutics Inc. (VKTX) returned about +36.8% a year annualized (+2188.2% cumulative total return).
What is Viking Therapeutics Inc.'s return since inception?
Since 2015, Viking Therapeutics Inc. (VKTX) has compounded at about +10.5% a year — +214.6% in total.

More on Viking Therapeutics Inc.